UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 124

Sortiert nach

Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network

Annals of oncology, 2014-01, Vol.25 (1), p.126-131

2014

Volltextzugriff (PDF)

Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC)

Annals of oncology, 2005-01, Vol.16 (1), p.90-96

2005

Volltextzugriff (PDF)

Quality Improvement Guidelines for Bone Tumour Management

Cardiovascular and interventional radiology, 2010-08, Vol.33 (4), p.706-713

2010

Volltextzugriff (PDF)

Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01)

Annals of oncology, 2011-05, Vol.22 (5), p.1154-1163

2011

Volltextzugriff (PDF)

Vaccines for the treatment of non-small cell lung cancer

Revue des maladies respiratoires, 2019-03, Vol.36 (3), p.415

2019

Volltextzugriff (PDF)

Oral single-agent chemotherapy in older patients with solid tumours: A position paper from the International Society of Geriatric Oncology (SIOG)

European journal of cancer (1990), 2015-11, Vol.51 (17), p.2491-2500

2015

Volltextzugriff (PDF)

Randomized phase II–III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: results from the IFCT-0802 trial

Annals of oncology, 2015-05, Vol.26 (5), p.908-914

2015

Volltextzugriff (PDF)

CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients

British journal of cancer, 2004-06, Vol.90 (11), p.2097-2105

2004

Volltextzugriff (PDF)

Platinum drugs in the treatment of non-small-cell lung cancer

British journal of cancer, 2002-10, Vol.87 (8), p.825-833

2002

Volltextzugriff (PDF)

Randomised phase II study of ASA404 combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer

British journal of cancer, 2008-12, Vol.99 (12), p.2006-2012

2008

Volltextzugriff (PDF)

Preoperative Chemotherapy Followed by Surgery Compared With Primary Surgery in Resectable Stage I (Except T1N0), II, and IIIa Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2002-01, Vol.20 (1), p.247-253

Depierre, A.

2002

Volltextzugriff (PDF)

Radiation-induced lung toxicity predictors: Retrospective analysis of 90 patients treated with stereotactic body radiation therapy for stage I non-small-cell lung carcinoma

Cancer radiothérapie, 2020-04, Vol.24 (2), p.120-127

2020

Volltextzugriff (PDF)

IFCT-1502 CLINIVO: real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancer

ESMO open, 2022-02, Vol.7 (1), p.100353-100353, Article 100353

2022

Volltextzugriff (PDF)

Detection of K-Ras mutations in tumour samples of patients with non-small cell lung cancer using PNA-mediated PCR clamping

British journal of cancer, 2009-03, Vol.100 (6), p.985-992

2009

Volltextzugriff (PDF)

Randomized Study of Maintenance Vinorelbine in Responders With Advanced Non–Small-Cell Lung Cancer

JNCI : Journal of the National Cancer Institute, 2005-04, Vol.97 (7), p.499-506

2005

Volltextzugriff (PDF)

Epidemiological novelties in lung cancer

Revue des maladies respiratoires, 2011-10, Vol.28 (8), p.1048

2011

Volltextzugriff (PDF)

Stereotactic body radiation radiotherapy for oligometastatic non-small cell lung cancer (NSCLC): A case report

Cancer radiothérapie, 2015-05, Vol.19 (3), p.192-197

2015

Volltextzugriff (PDF)

Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3

The European respiratory journal, 2012-01, Vol.39 (1), p.172-179

2012

Volltextzugriff (PDF)

Asteatotic eczema ('eczema craquelé') with histopathological interface dermatitis: a new cutaneous reaction following pemetrexed

British journal of dermatology (1951), 2012-06, Vol.166 (6), p.1359-1360

2012

Volltextzugriff (PDF)

Novel epidemiology in lung cancer - non-smokers, women and cannabis

Revue des maladies respiratoires, 2007-10, Vol.24 (8 Pt 2), p.6S10

Quoix, E

2007

Volltextzugriff (PDF)

EGFR-TKI and lung adenocarcinoma with CNS relapse: interest of molecular follow-up

The European respiratory journal, 2009-02, Vol.33 (2), p.436-440

2009

Volltextzugriff (PDF)

Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer : Groupe Français de Pneumo-Cancérologie (GFPC) Protocol 95-1

Annals of oncology, 2001, Vol.12 (1), p.59-67

2001

Volltextzugriff (PDF)

The increasing incidence of lung adenocarcinoma : Reality or artefact? A review of the epidemiology of lung adenocarcinoma

International journal of epidemiology, 1997-02, Vol.26 (1), p.14-23

1997

Volltextzugriff (PDF)

Etoposide Plus Cisplatin With or Without the Combination of 4′-Epidoxorubicin Plus Cyclophosphamide in Treatment of Extensive Small-Cell Lung Cancer: a French Federation of Cancer Institutes Multicenter Phase III Randomized Study

JNCI : Journal of the National Cancer Institute, 2001-02, Vol.93 (4), p.300-308

2001

Volltextzugriff (PDF)

1 – 25 von 124

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(117)
Mit Volltextzugriff
(101)

Publikationsform

Artikel
(124)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(124)
Humans
(113)
Male
(80)
Oncology
(76)
Female
(73)
Middle Aged
(69)
Aged
(63)
Respiratory System
(53)
Biological And Medical Sciences
(51)
Medical Sciences
(51)
Lung Neoplasms - Drug Therapy
(44)
Lung Neoplasms - Pathology
(43)
Adult
(42)
Pneumology
(32)
Tumors Of The Respiratory System And Mediastinum
(31)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(28)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(26)
Aged, 80 And Over
(23)
Chemotherapy
(23)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network

Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC)

Quality Improvement Guidelines for Bone Tumour Management

Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01)

Vaccines for the treatment of non-small cell lung cancer

Oral single-agent chemotherapy in older patients with solid tumours: A position paper from the International Society of Geriatric Oncology (SIOG)

Randomized phase II–III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: results from the IFCT-0802 trial

From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the french intergroup (IFCT) and the groupe d'Oncologie de langue française (GOLF)

CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients

Platinum drugs in the treatment of non-small-cell lung cancer

Randomised phase II study of ASA404 combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer

Preoperative Chemotherapy Followed by Surgery Compared With Primary Surgery in Resectable Stage I (Except T1N0), II, and IIIa Non–Small-Cell Lung Cancer

Radiation-induced lung toxicity predictors: Retrospective analysis of 90 patients treated with stereotactic body radiation therapy for stage I non-small-cell lung carcinoma

IFCT-1502 CLINIVO: real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancer

Detection of K-Ras mutations in tumour samples of patients with non-small cell lung cancer using PNA-mediated PCR clamping

Randomized Study of Maintenance Vinorelbine in Responders With Advanced Non–Small-Cell Lung Cancer

Epidemiological novelties in lung cancer

Stereotactic body radiation radiotherapy for oligometastatic non-small cell lung cancer (NSCLC): A case report

Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3

Asteatotic eczema ('eczema craquelé') with histopathological interface dermatitis: a new cutaneous reaction following pemetrexed

Novel epidemiology in lung cancer - non-smokers, women and cannabis

EGFR-TKI and lung adenocarcinoma with CNS relapse: interest of molecular follow-up

Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer : Groupe Français de Pneumo-Cancérologie (GFPC) Protocol 95-1

The increasing incidence of lung adenocarcinoma : Reality or artefact? A review of the epidemiology of lung adenocarcinoma

Etoposide Plus Cisplatin With or Without the Combination of 4′-Epidoxorubicin Plus Cyclophosphamide in Treatment of Extensive Small-Cell Lung Cancer: a French Federation of Cancer Institutes Multicenter Phase III Randomized Study

Aktive Filter

Suchergebnisse filtern